Last reviewed · How we verify
NCT05640453
Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting
Phase 4 trial testing Pregabalin in Pregabalin in 70 participants. Currently enrolling.
15 May 2026
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 15 December 2022 |
| Primary completion | 15 May 2026 |
| Estimated completion | 15 May 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Pregabalin (Pregabalin) — full drug profile →
- Dexmedetomidine (dexmedetomidine) — full drug profile →
Conditions studied
- Pregabalin — all drugs for Pregabalin →
- Delirium Treatment — all drugs for Delirium Treatment →
- Coronary Artery Bypass Grafting — all drugs for Coronary Artery Bypass Grafting →
- Dexmedetomidine — all drugs for Dexmedetomidine →
Sponsor
Tanta University
Who can join
65 and older, any sex, with Pregabalin or Delirium Treatment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05640453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pregabalin
Trials testing the same drug.
- NCT07288528 — A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Ref · Phase 4 · not yet recruiting
- NCT07421427 — Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome · NA · recruiting
- NCT07275762 — Y-4 to Treat the Postherpetic Neuralgia · Phase 2 · recruiting
- NCT07208357 — The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With Fibromyalgia · NA · recruiting
- NCT07196657 — The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia · NA · recruiting
Other recruiting trials for Pregabalin
Currently open trials in the same condition.
- NCT07421427 — Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome · NA · recruiting
- NCT07275762 — Y-4 to Treat the Postherpetic Neuralgia · Phase 2 · recruiting
- NCT07344467 — Oral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery · NA · recruiting
- NCT07208357 — The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With Fibromyalgia · NA · recruiting
- NCT07196657 — The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia · NA · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05640453 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 25 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05640453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing